Bedford, Massachusetts-based orthopedic medical device company ConforMIS has filed a registration statement with the Securities and Exchange Commission (SEC) announcing that the company intends to go public and raise $172.5 Million. According to the documents filed with the SEC, the company has not priced the range at which the stock will go public. The stock will be listed as CFMS in the NASDAQ stock exchange.
Founded in 2004, ConforMIS develops and commercializes medical devices for the treatment of osteoarthritis and joint damage. ConforMIS transforms patient CT data into customized implants with a complete set of patient-specific instrumentation using its proprietary iFIT technology. According to the company’s website, ConforMIS maintains a portfolio of over 375 patents and patent applications in the areas of image processing, patient-specific implant systems, patient-specific surgical techniques, patient-specific instrumentation, and manufacturing across multiple joints.
In April, ConforMIS settled patent infringement lawsuits against Wright Medical by granting a license to the company.
